About Dimitrios Iliopoulos
Dimitrios Iliopoulos is a president & CEO, director at Athos Therapeutics.
Dimitrios Iliopoulos first appears on SEC filings in 2021.
Experience
This experience comes from Dimitrios Iliopoulos's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dimitrios Iliopoulos in the role, so the role may have started earlier or lasted longer.
Athos Therapeutics, Inc. Current
Co-founder, President & CEO (2019 – Present)
Director
2019 – Present · Torrance, CA
Develops AI-assisted medicines for people with autoimmune and inflammatory diseases.
DH
Dyania Health Current
Co-founder, Member Board of Directors
2019 – Present
AR
ARISTEiA Current
Vice President
2019 – Present
AL
Attica Sciences Ltd Current
Co-Founder
2018 – Present
AP
Athens LifeTech Park
Member Board of Directors
2023 – 2025
BP
Biotech/Pharma
Biotech Finance & Strategy Consultant
2014 – 2018
US
UCLA Health System
Associate Professor of Medicine
2012 – 2018
DI
Dana-Farber Cancer Institute
Assistant Professor
2010 – 2012
DS
Department of Microbiology & Immunobiology, Harvard Medical School
Assistant Professor
2010 – 2012
HU
Harvard University
Post-doctoral Fellow
2007 – 2010
Key Colleagues at Startups
The people Dimitrios Iliopoulos works with at each company, as listed on that company's latest Form D.
Athos Therapeutics, Inc. · Form D, May 15, 2026
CM
Carl McKinzie
Member of the Board
LS
Laurence Stein
Member of the Board
JC
Joel Cohen
Member of the Board
AZ
Anthony Zingale
Director
AP
Allan Pantuck
Chairman & CMO